Recombinant Human Erythropoietin for the Treatment of Anaemia in Patients with Chronic Idiopathic Myelofibrosis

Publisher： Karger

E-ISSN： 1421-9662|117|3|156-161

ISSN： 0001-5792

Source： Acta Haematologica, Vol.117, Iss.3, 2006-12, pp. : 156-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human Erythropoietin in the Treatment of Chronic Anemia of Cancer

By  

Acta Haematologica, Vol. 100, Iss. 2, 1998-10 ,pp. : 115-115

Karger

Access to resources Recommend Favorite

Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients

By Kwan Jonathan T. C.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 307-311

Informa Healthcare

Access to resources Recommend Favorite

Impact of anaemia treatment for left ventricular remodelling prior to initiation of dialysis in chronic kidney disease patients: Efficacy and stability of long acting erythropoietin stimulating agents

By  

NEPHROLOGY, Vol. 20, Iss. S4, 2015-12 ,pp. : 7-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of β-Thalassemia Patients with Recombinant Human Erythropoietin: Effect on Transfusion Requirements and Soluble Adhesion Molecules

By  

Acta Haematologica, Vol. 111, Iss. 4, 2004-05 ,pp. : 189-195

Karger

Access to resources Recommend Favorite

HX575, Recombinant Human Epoetin Alfa, for the Treatment of Chemotherapy-Associated Symptomatic Anaemia in Patients with Solid Tumours

By  

Oncology Research and Treatment, Vol. 32, Iss. 4, 2009-03 ,pp. : 168-174

Karger

Access to resources Recommend Favorite